Q-omics provides the consensus-scored MIR521-2 profile across patient tissues and cancer cell-line models. MIR521-2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, MIR521-2 RNA expression shows 8,568 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight PAAD, and TGCT as cancer lineages where MIR521-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR521-2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MIR521-2 survival associations across molecular data types. MIR521-2 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR521-2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	PAAD (36)	view →

This table ranks reproducible MIR521-2 RNA expression–survival associations across cancer types. High MIR521-2 expression shows unfavorable associations in PAAD, UCEC, STAD, SARC, LIHC and TGCT. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for MIR521-2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.100	0.590	<.001	36	view →
UCEC	OS	Tertile	All	0.855	0.929	.011	30	view →
STAD	DFS	Tertile	III,IV	0.203	0.491	.025	18	view →
SARC	OS	Tertile	All	0.176	0.839	.001	18	view →
LIHC	DFS	Tertile	All	0.289	0.557	.033	18	view →
TGCT	DFS	Tertile	All	0.689	0.879	.013	12	view →

Pink = unfavorable, green = favorable. all 8 lineages →

MIR521-2-PAAD (OS)

Kaplan–Meier survival curve for MIR521-2 RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MIR521-2 in patient tissues and cancer cell lines. In patient samples, MIR521-2 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	8,568	TGCT (4157)	view →
Function (RNA)	6,326	STAD (5602)	view →
▼Mutation
RNA	27	UCEC (22)	view →